Soaring EpiPen prices raise questions about pharmaceutical industry
CBS Boston - 10/21/2015
Professor Todd Brown, who teaches at Northeastern University’s School of Pharmacy, said the increase in prices is, “a bigger issue across most medications in general now.”
Brown added, “Pharmaceutical companies have really changed the way they price medications. It used to be related to the impact of the medication. And now it has really changed essentially to how much they can get for a medication.”
This is a real problem in the United States. For example, those same EpiPens which cost about $400 here can be purchased for about $85 in France.